Delirium, Dementia, Amnestic, Cognitive Disorders
Welcome,         Profile    Billing    Logout  
 122 Companies   196 Products   196 Products   116 Mechanisms of Action   3 Trials   2338 News 


«12...4567891011121314...4647»
  • ||||||||||  rivastigmine transdermal / Generic mfg.
    Trial completion:  Rivastigmine in the Management of Delirium (clinicaltrials.gov) -  Jul 21, 2016   
    P3,  N=23, Completed, 
    Active, not recruiting --> Completed
  • ||||||||||  osoresnontrine (BI 409306) / Boehringer Ingelheim
    Trial primary completion date:  Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo (clinicaltrials.gov) -  Jul 19, 2016   
    P2,  N=288, Recruiting, 
    Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Apr 2016 Trial primary completion date: May 2017 --> Sep 2017
  • ||||||||||  Biomarker, Trial primary completion date:  Down Syndrome Biomarker Initiative (DSBI) (clinicaltrials.gov) -  Jul 19, 2016   
    P=N/A,  N=12, Active, not recruiting, 
    Trial primary completion date: May 2017 --> Sep 2017 Trial primary completion date: Jun 2016 --> Dec 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Exploratory Study for the Validity of QuQu Scale (clinicaltrials.gov) -  Jul 15, 2016   
    P=N/A,  N=972, Completed, 
    Not yet recruiting --> Recruiting | Trial primary completion date: May 2016 --> Sep 2016 Recruiting --> Completed | N=400 --> 972 | Trial primary completion date: Dec 2015 --> Mar 2016
  • ||||||||||  Enrollment closed, Trial primary completion date:  Brain Alterations and Cognitive Impairment in Older Adults With Heart Failure (clinicaltrials.gov) -  Jun 23, 2016   
    P=N/A,  N=40, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2016 --> Dec 2016
  • ||||||||||  Trial completion, Trial primary completion date:  PET Imaging in Chronic Traumatic Encephalopathy (clinicaltrials.gov) -  Jun 23, 2016   
    P=N/A,  N=6, Completed, 
    Recruiting --> Completed | Trial primary completion date: Aug 2012 --> Aug 2015 Suspended --> Completed | Trial primary completion date: Sep 2016 --> Jun 2016
  • ||||||||||  Biomarker:  Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease (clinicaltrials.gov) -  Jun 21, 2016   
    P=N/A,  N=60, Active, not recruiting, 
    Suspended --> Completed | Trial primary completion date: Sep 2016 --> Jun 2016 Trial primary completion date: Sep 2016 --> Sep 2017
  • ||||||||||  Enrollment closed, Trial primary completion date:  Post-Operative Delirium in Elderly Surgical Patients (clinicaltrials.gov) -  Jun 12, 2016   
    P=N/A,  N=200, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> May 2017
  • ||||||||||  Trial completion:  DRIVE COG: Ability to Drive of Early Stage Alzheimer Disease (clinicaltrials.gov) -  Jun 10, 2016   
    P=N/A,  N=60, Completed, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2016 --> May 2017 Not yet recruiting --> Completed
  • ||||||||||  Trial primary completion date:  18F-AV-1451 High Resolution Autopsy Study (clinicaltrials.gov) -  May 31, 2016   
    P1,  N=10, Recruiting, 
    Recruiting --> Completed Trial primary completion date: Nov 2016 --> Jun 2017
  • ||||||||||  Trial completion, Phase classification, Enrollment change, Trial primary completion date:  Bioavailability of Ubiquinol in Huntington Disease (clinicaltrials.gov) -  May 27, 2016   
    P1,  N=6, Completed, 
    Trial primary completion date: Nov 2016 --> Jun 2017 Recruiting --> Completed | Phase classification: PN/A --> P1 | N=12 --> 6 | Trial primary completion date: Mar 2010 --> Jul 2012
  • ||||||||||  Enrollment closed:  Physical Activity and Neuropsychological Outcomes in a Cancer Population (clinicaltrials.gov) -  May 27, 2016   
    P=N/A,  N=87, Active, not recruiting, 
    Recruiting --> Completed | Phase classification: PN/A --> P1 | N=12 --> 6 | Trial primary completion date: Mar 2010 --> Jul 2012 Recruiting --> Active, not recruiting
  • ||||||||||  Trial termination:  Music Therapy in Alzheimer's Disease (clinicaltrials.gov) -  May 26, 2016   
    P=N/A,  N=35, Terminated, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Apr 2016 Completed --> Terminated
  • ||||||||||  donanemab (LY3002813) / Eli Lilly
    Trial primary completion date:  A Study of LY3002813 in Participants With Alzheimer's Disease (clinicaltrials.gov) -  May 23, 2016   
    P1,  N=100, Active, not recruiting, 
    Active, not recruiting --> Completed | N=100 --> 65 Trial primary completion date: Sep 2016 --> Jan 2017
  • ||||||||||  lisdexamfetamine / Generic mfg.
    Enrollment change, Trial withdrawal, Trial primary completion date:  LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy (clinicaltrials.gov) -  May 13, 2016   
    P=N/A,  N=0, Withdrawn, 
    Completed --> Terminated N=20 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2017 --> Dec 2013
  • ||||||||||  Enrollment closed, Trial primary completion date:  CBTAC: Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers (clinicaltrials.gov) -  May 13, 2016   
    P2,  N=50, Active, not recruiting, 
    N=20 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Oct 2017 --> Dec 2013 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2016 --> Sep 2017
  • ||||||||||  Trial completion:  4-question "RACY" Delirium Screening Tool Validation Study (clinicaltrials.gov) -  May 13, 2016   
    P=N/A,  N=1093, Completed, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2015 --> Apr 2016 Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed, Enrollment change:  Actigraphy to MEasuRe Intensive Care Unit Activity (clinicaltrials.gov) -  May 12, 2016   
    P=N/A,  N=25, Active, not recruiting, 
    Active, not recruiting --> Completed Recruiting --> Active, not recruiting | N=75 --> 25
  • ||||||||||  Trial primary completion date:  Energy Metabolism and Cognitive Aging (clinicaltrials.gov) -  May 12, 2016   
    P4,  N=40, Recruiting, 
    Recruiting --> Active, not recruiting | N=75 --> 25 Trial primary completion date: Dec 2015 --> Dec 2016